shielding and swabbing to detect COVID before elective cancer surgery [COVID-19]
Research type
Research Study
Full title
CHICANE: A Cohort Study to Assess the Effectiveness of Preoperative Shielding and Nose and Throat RT-PCR Swabbing for Elective Cancer Surgery Patients in the COVID-19 Pandemic\n
IRAS ID
284175
Contact name
Robert Jones
Contact email
Sponsor organisation
Liverpool University Hospitals NHS Foundation Trust
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 2 months, 3 days
Research summary
There is evidence to suggest that operating of COVID-19 positive patients leads to an increased mortality rate. With elective cancer surgery now increasing in the UK it is key to identify patients who have COVID-19 but are asymptomatic. The optimal method for screening patients for COVID infection before elective cancer surgery is unclear. Many centres across the UK, including Liverpool University Hospitals NHS Foundation Trust, have decided to screen patients preoperatively for COVID, asking patients to report symptoms prior to surgery as well as swabbing patients before operating. The aim of this study is to assess this screening process.
REC name
Yorkshire & The Humber - Leeds West Research Ethics Committee
REC reference
20/YH/0189
Date of REC Opinion
8 Jun 2020
REC opinion
Favourable Opinion